Gregory T. Went, Chief Executive Officer at Adamas Pharmaceuticals Inc (ADMS), bought 3,850 shares at $12.98 ($50K) on 2018-11-07, disclosed to the SEC on 2018-11-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |
| ADMS | SELL | 2015-04-27 | $59K | — | Filing → |